Skip to main content
Covid-19 second wave in Mumbai, India.
War in Gaza:: find out how we're responding
Learn more
We fill gaps in India’s health system and provide specific medical care to neglected people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address specific healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Key activities

Our activities in 2022 in India

Data and information from the International Activity Report 2022.

MSF in India in 2022 In India, Médecins Sans Frontières (MSF) continued to provide treatment for patients living with drug-resistant tuberculosis (DR-TB) and HIV, and medical and psychological care for people affected by conflict and violence.
India IAR map 2022

In the capital, New Delhi, we run a clinic for victims of sexual and gender-based violence, offering round-the-clock care. In December, we organised a national-level symposium calling for better access to medical and psychological care for victims.

Throughout the year, we provided mental health and psychosocial support to people affected by the conflict in Kashmir, and ran mobile clinics offering basic healthcare to communities in remote areas of Chhattisgarh.

In Mumbai, MSF’s clinic focuses on treating complex cases of DR-TB, including extensively drug-resistant forms of the disease, with innovative drug combinations. For children under five, we implement all-oral regimens, thereby avoiding the need for painful injections.

In addition, we are working with the National Tuberculosis Elimination Programme and Municipal Corporation of Greater Mumbai to reduce the high TB incidence and death rates in the area. Our team co-manages a DR-TB centre in a public hospital, and we support diagnosis, treatment, counselling, health promotion and follow-up in general healthcare facilities.

In 2022, we also continued treating patients enrolled in the endTB clinical trial, with the aim of generating more evidence for shorter, more tolerable, injection-free treatments for multidrug-resistant TB.

Our project in Manipur implements a person-centred care approach for people living with HIV, TB, DR-TB and hepatitis C. We transferred many of our stable HIV patients to Ministry of Health facilities, enabling us to focus on those with co-infections and complications. We also run a one-stop care centre offering comprehensive services for intravenous drug users.

In one of India’s poorest states, Bihar, we provide both lifesaving and palliative care to patients living with advanced HIV.

Our toll-free telemedicine helpline supports diabetes patients to manage their condition. India has the second-highest burden of diabetes globally, and the prevention and management of the disease, as well as its associated complications, remain a huge challenge.

 

In 2022
Kala azar-HIV co-infection in Bihar, Animated explainer | ENG
video

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

 
India

Must address worrying stock out of tuberculosis drugs

Press Release 17 Jun 2013
 
Activists from across Europe stage flashmob in front of the European Parliament
Project Update

EU-India free trade deal puts millions of lives at risk

Press Release 9 Apr 2013
 
India

Indian supreme court delivers verdict in Novartis case

Press Release 1 Apr 2013
 
FTA Protest Delhi - February 2012
India

Under pressure from Europe to sign off on trade deal that will harm access to medicines

Project Update 13 Mar 2013
 
India

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

Statement 18 Jan 2013
 
India

Double frontal attack on the 'pharmacy of the developing world'

Voices from the Field 17 Sep 2012
 
India

Novartis challenges pro-health patent law

Press Release 11 Sep 2012
 
India

Bayer attempting to block affordable patented drugs

Press Release 3 Sep 2012
 
India

Patients struggle to find MDR-TB treatment

Project Update 12 Jul 2012
 
India

MSF launches new Novartis campaign

Project Update 15 Feb 2012
 
India

About the Novartis Drop the Case campaign

Project Update 15 Feb 2012
 
India

Open letter from MSF President to Indian PM Manmohan Singh on FTA

Project Update 10 Feb 2012

Contact us

Treating kala azar-HIV co-infection in Bihar, India